Globus Medical
GMED
364 hedge funds and large institutions have $4.01B invested in Globus Medical in 2022 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 118 increasing their positions, 128 reducing their positions, and 64 closing their positions.
3.47% more ownership
Funds ownership: 87.87% → 91.35% (+3.5%)
8% less repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 128
9% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 64
3% less funds holding
Funds holding: 377 → 364 (-13)
15% less call options, than puts
Call options by funds: $16.2M | Put options by funds: $19M
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
21% less capital invested
Capital invested by funds: $5.08B → $4.01B (-$1.06B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$167M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$90.1M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$45.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$40.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$30.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$36.9M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$36.5M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$32.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.5M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$22.1M |
GMED Hedge Fund Activity: Q2 2022 in Review
364 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2022, worth a combined $4.01B — down 21% from $5.08B a quarter earlier.
Sellers outnumbered buyers: 64 funds closed out of GMED and 58 opened new positions — a net loss of 6 holders — while 128 trimmed existing stakes and 118 added.
The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $167M. The largest seller was RTW Investments, cutting an estimated $36.9M.
- 364 institutional investors held Globus Medical (GMED) as of Q2 2022, down from 377 in Q1 2022.
- Funds reported $4.01B of Globus Medical stock for Q2 2022, down 21% quarter-over-quarter.
- 58 funds opened new Globus Medical positions in Q2 2022 and 64 closed out, a net change of -6 holders.
- The largest Globus Medical buyer in Q2 2022 was Kayne Anderson Rudnick Investment Management, an estimated $167M added.
- The largest Globus Medical seller in Q2 2022 was RTW Investments, an estimated $36.9M sold.
Based on aggregated 13F filings for Q2 2022.